本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

18.83
-0.4300-2.23%
盤前19.410.5800+3.08%08:33 EDT
成交量:117.21萬
成交額:2,198.59萬
市值:23.67億
市盈率:-10.48
高:19.15
開:19.01
低:18.51
收:19.26
資料載入中...
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities